4 days ago · At UCB, we believe that everyone deserves to live the best life that they can. That’s why – as a global biopharmaceutical leader - we’re focused on creating valuable solutions that …
A global biopharma company, inspired by the needs of people living with severe diseases. At UCB, we are consistently delivering on our commitment to improve the lives of people living …
minzasolmin belongs to a series of molecules discovered by Neuropore, which were in-licensed by UCB in 2014. minzasolmin is being co-developed with Novartis. UCB0022 (D1 receptor …
At UCB, innovation goes into the medicines we discover, develop, and deliver. To achieve this, we work hard at providing the right surroundings and facilities, creating a culture that nurtures and …
Let's push the boundaries together and make the most of your talents. Find available jobs in fields like Finance, Medical & Clinical, Sales & Marketing and more
For many years, UCB has responded to changing needs for better healthcare. Our medicines aim to bring longer lives and healthier living to people all over the world. Our medicines are …
Dec 2, 2021 · UCB Biopharma. UCB Initiates Phase 1b US-Based Multicenter Clinical Trial in Parkinson’s Disease Patients with UCB0599, a Compound Arising from the Neuropore-UCB …
At UCB, we aspire to be the patient-preferred biotech leader. To achieve this goal, UCB has become an innovation-driven global biopharmaceutical company creating value for patients, …